Publications by authors named "John Byron"

Claim this Profile
A
A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
Janet S Rader, Michael W Sill, Jan H Beumer, Heather A Lankes, Doris Mangiaracina Benbrook, John Byron

Gynecol Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preference elicitation tool for abnormal uterine bleeding treatment: a randomized controlled trial.
Lisa M Hess, Abigail Litwiller, John Byron, John Stutsman, Kelly Kasper

Patient· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia.
Francisco A R Garcia, Terri Cornelison, Tomas Nuño, David L Greenspan, John W Byron

Gynecol Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.
Antonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, Jonathan Beesley, Xiaoqing Chen, John Byron

Breast Cancer Res· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.
Deborah M Friedman, Carolina Llanos, Peter M Izmirly, Brigit Brock, John Byron

Arthritis Rheum· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis